VEHA Health Care Education LLP seal VEHAHealth Care Education LLP

Hyderabad, India · Est. 2024

Newborn care
should not depend
on a customs form.

VEHA Health Care Education LLP builds the devices, software and training that neonatal units in India actually need — designed at the cot side, priced for the hospitals that treat the most babies.

The iNO-VEN inhaled nitric oxide prototype on a workbench, showing its 7-inch touchscreen on the cyan and grey housing
iNO-VEN, prototype unit — India's first indigenous inhaled nitric oxide delivery and monitoring system.
5
Products across devices, software, education and AI
10,000+
Clinician downloads of NeonatAI
6
Indian languages supported in KMC Sparsha
>70%
Cost reduction targeted by iNO-VEN vs imported systems

02 Why we exist

The gap isn't knowledge.
It's access.

Indian NICUs know exactly what to do for a baby in hypoxic respiratory failure. What they often don't have is the machine, the reference at 3 a.m., or the staffing to run a structured KMC programme.

Built by the people using it

Every product starts with a neonatologist's complaint about a real shift, not a market-sizing deck.

Priced for the district hospital

If only twenty tertiary centres can afford it, it hasn't solved anything. Cost is a design constraint, not an afterthought.

Standards from day one

ISO 13485 QMS, ISO 14971 risk management and IEC 60601 design controls applied from the first schematic.

India first, then everywhere like India

80% of the global PPHN and PAH burden sits in low- and middle-income countries. What works here travels.

03 The founder

Dr. Venkat Reddy Kallem, Consultant Neonatologist and Head of Neonatology at Paramitha Hospitals, Hyderabad
Consultant Neonatologist & Head of Neonatology, Paramitha Hospitals, Hyderabad

Dr. Venkat Reddy Kallem

Founder, Director & Chief Medical Officer

MBBS, DNB (Paediatrics), DrNB (Neonatology)

Every product here started as something we needed on a night shift and could not buy.

A practising neonatologist with over six years in neonatal critical care, experienced in managing PPHN and hypoxic respiratory failure. He founded VEHA to close the distance between what neonatal medicine can do and what an Indian NICU can actually reach for — and is the clinical author behind all four products.

He is the clinical author of NeonatAI, the founder of Vaidhya Edu, and the driving force behind iNO-VEN — which is why the four products fit together rather than merely sharing a letterhead.

And the bench behind him

Clinical credibility only ships if someone can build the thing. VEHA pairs the medicine with engineers who have put clinical-grade electronics into production before.

Meet the full team

Dr. Suman Rao, Professor of Neonatology and WHO consultant

Dr. Suman Rao

MBBS, MD (Paediatrics), DM (Neonatology)

Professor of Neonatology, St. John's Medical College, Bengaluru · WHO consultant

Adithya Chilka

Co-Founder & Biomedical Engineering Lead · 7+ years in healthcare IoT & medical device design

Robin Samuel

Hardware & Electronics Lead · 7+ years in medical electronics & biosignal platforms

04 Recognition & standing

On the record

iNO-VEN presented at NEOCON 2025, the 44th National Neonatology Forum conference, Visakhapatnam — Innovations category.
Indian patent filed — Nitric Oxide Therapy Machine, Indian Patent Office. iNO-VEN trademark registered (Class 10).
CDSCO Class C/D test licence application submitted. ISO 13485:2016 QMS under implementation and certification.
Incubation and support engagements with T-Hub, AMTZ, CCMB and Amrita TBI. MSME / Startup India registered.
BIRAC BIG grant applied for. CE Mark Class IIb/III international pathway underway.
NeonatAI rated 5 stars by neonatologists on Google Play, with 10,000+ downloads across iOS and Android.
The VEHA team receiving recognition for iNO-VEN on stage at NEOCON 2025 in Visakhapatnam, with the device shown on the screen behind them
NEOCON 2025, Visakhapatnam — iNO-VEN presented under the Innovations category at the 44th Annual Conference of the National Neonatology Forum.

05 Common questions

What does VEHA Health Care Education LLP do?

VEHA Health Care Education LLP is a Hyderabad-based neonatal healthcare company. It develops iNO-VEN, an indigenous inhaled nitric oxide delivery and monitoring system; NeonatAI, a bedside clinical decision-support app for NICU teams; KMC Sparsha, a Kangaroo Mother Care programme tracking platform; Vaidhya Edu, a medical education platform for healthcare professionals; and VEHA Clinical Intelligence, an AI-assisted clinical operations platform currently in development.

Where is VEHA based, and who does it serve?

VEHA is based in Hyderabad, Telangana, India. Its products are designed for neonatal, paediatric and adult intensive care units across India — from premier tertiary centres to district and Tier-2 hospitals — and for low- and middle-income countries facing the same access constraints.

Who founded VEHA?

VEHA was founded by Dr. Venkat Reddy Kallem, a practising neonatologist holding MBBS, DNB (Paediatrics) and DrNB (Neonatology). He serves as Founder, Director and Chief Medical Officer, and is also the creator of the Vaidhya Edu education platform.

Are VEHA products available outside India?

NeonatAI is available worldwide on the Google Play Store and the Apple App Store. KMC Sparsha is available on the web and on Android. iNO-VEN is currently in CDSCO regulatory submission for the Indian market, with a CE Mark Class IIb/III pathway planned for international markets.

How can a hospital start working with VEHA?

Hospitals can request an iNO-VEN clinical evaluation partnership or early-access pilot, request KMC Sparsha programme access, or download NeonatAI directly from either app store. For anything else, email the team at support@vehahealthcare.com.

06 Get in touch

Partner with us
in saving lives.

We are actively looking for clinical evaluation partners, investors, OEM manufacturing partners and hospital networks who want neonatal technology that reaches past the metros.